Learn how to transform a 3.7V battery to power a 220V device with this step-by-step mini inverter tutorial. Discover the essential components and techniques needed to build this useful DIY project ...

Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Mumbai: Two major infrastructure projects Phase 2 of the Metro-3 corridor and the final phase of the Samruddhi Expressway most likely to be opened to the public on May 1st According to sources ...

PANOVA-3 is an international, prospective, randomized, open-label, controlled Phase 3 clinical trial designed to test the efficacy and safety of Tumor Treating Fields (TTFields) therapy used ...

In its first global phase 3 readout, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody ivonescimab reduced the risk of progression or death by 48% in patients with ...

A randomized phase 3 study of ivonescimab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of metastatic non–small cell lung cancer: HARMONi-3.

Kuro Games announced all the events and banners coming with Wuthering Waves 2.3 second phase. Since the ongoing update features the game's first anniversary, quite a few gameplay events are packed ...

Plug Power has gotten torched over the last six months - since November 2024, its stock price has dropped 59.4% to $0.80 per share. This was partly due to its softer quarterly results and may have ...

Understand YSK110 70 4 220v 70w single phase capacitor asynchronous fan motor for air conditioner information in Changzhou Trustec Company Limited company, and quickly obtain the latest quotation, ...

BSEB has released the BSEB Teacher Competency schedule 2025 for the third, fourth, and fifth phase. The exam shall be held between May and July. Check complete datesheet, important dates with ...

Nearly a year after winning an accelerated approval for its DLL3-targeting small cell lung cancer (SCLC) therapy Imdelltra, Amgen is further proving the drug's worth with overall survival data ...

Now, ITM is providing details of that phase 3 win—while acknowledging that another survival endpoint wasn’t quite as successful.